These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 36536701)

  • 1. Assessment of safety and adverse drug reactions of COVID vaccination in the South Indian population: An observational prospective cross-sectional study.
    Manda A; Koya P; Pallem R; Mohd D; Thatikonda K; Venkateshwarlu K
    Ann Med Surg (Lond); 2022 Dec; 84():104948. PubMed ID: 36536701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of COVID-19 Vaccination on Menstrual Cycle Patterns of Reproductive-age Women: A Multi-centric Observational Study.
    Kumar N; Gangane N; Mohapatra I; Rukadikar C; Sharmila V; Pushpalatha K; Eerike M; Santhoshi G; Samantaray SR; Seth S; Trigunait P; Reddy NJ; Patel S; Rani S; Mishra R; Negi K
    Curr Drug Res Rev; 2024; 16(2):237-248. PubMed ID: 37291775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ADR Profile of the Covishield Vaccine Among Healthcare Workers in a Tertiary Care Teaching Hospital in India.
    Deb T; Garg R; Kaur M; Beniwal A; Gupta V
    Curr Drug Saf; 2022; 17(4):344-349. PubMed ID: 35049437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety Surveillance of Covishield Vaccine-Associated Adverse Events During the COVID-19 Pandemic: A Retrospective Longitudinal Study.
    Chaudhary S; Aggarwal M; Kumari P; Vishwas G; Meshram GG; Dhaka R; Garg M
    Cureus; 2024 Aug; 16(8):e67257. PubMed ID: 39301361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of BBV152/Covaxin and AZD1222/Covishield vaccines against severe COVID-19 and B.1.617.2/Delta variant in India, 2021: a multi-centric hospital-based case-control study.
    Bhatnagar T; Chaudhuri S; Ponnaiah M; Yadav PD; Sabarinathan R; Sahay RR; Ahmed F; Aswathy S; Bhardwaj P; Bilimale A; Kumar MS; Logaraj M; Narlawar U; Palanivel C; Patel P; Rai SK; Saxena V; Singh A; Thangaraj JW; Agarwal A; Alvi Y; Amoghashree ; Ashok P; Babu D; Bahurupi Y; Bhalavi S; Behera P; Biswas PP; Charan J; Chauhan NK; Chetak KB; Dar L; Das A; Deepashree R; Dhar M; Dhodapkar R; Dipu TS; Dudeja M; Dudhmal M; Gadepalli R; Garg MK; Gayathri AV; Goel AD; Gowdappa HB; Guleria R; Gupta MK; Islam F; Jain M; Jain V; Jawahar MLS; Joshi R; Kant S; Kar SS; Kalita D; Khapre M; Khichar S; Kombade SP; Kohli S; Kumar A; Kumar A; Kumar D; Kulirankal KG; Leela KV; Majumdar T; Mishra B; Misra P; Misra S; Mohapatra PR; Murthy MN; Nyayanit DA; Patel M; Pathania M; Patil S; Patro BK; Jalandra R; Rathod P; Shah N; Shete A; Shukla D; Shwethashree M; Sinha S; Sumana MN; Surana A; Trikha A; Tejashree A; Venkateshan M; Vijaykrishnan G; Wadhava S; Wig N; Gupta N; Abraham P; Murhekar MV
    Int J Infect Dis; 2022 Sep; 122():693-702. PubMed ID: 35843496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Longitudinal Follow-Up Study on the Side Effects of COVID-19 Vaccines: A Telephonic Questionnaire Approach.
    Priya Jakkula K; Kishore J; Maheswar Rao U
    Cureus; 2024 Jun; 16(6):e62917. PubMed ID: 39040783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adverse effects after first and second dose of covishield and covaxin: A longitudinal study.
    Mittal A; Jain B; Varshney AM; Garg G; Sachan D; Singh RB
    J Family Med Prim Care; 2022 Nov; 11(11):7339-7345. PubMed ID: 36993127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Study to Describe the Pattern of Cutaneous Adverse Effects of COVID-19 Vaccines (Covishield and Covaxin).
    Saraswat N; Tripathy DM; Murali M; Boruah J; Mitra D; Chopra H; Bhatnagar A
    Indian Dermatol Online J; 2023; 14(6):814-820. PubMed ID: 38099027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adverse Events Following COVID-19 Vaccination in Selected Apartments in Bangalore, India.
    Chakraborty A; Reval N; Kamath L
    Cureus; 2022 Feb; 14(2):e21809. PubMed ID: 35291520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adverse drug reactions from two COVID-19 vaccines reported in Saudi Arabia.
    Alfaleh A; Alkattan A; Radwan N; Elzohri M; Alzaher A; Ibrahim M; Alsalameen E; Alsultan A; Alhabib D; Alshelwah A; Mahmoud N; Sagor K; Alabdulkareem K
    Drugs Ther Perspect; 2022; 38(2):84-92. PubMed ID: 35095267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunogenicity of two COVID-19 vaccines used in India: An observational cohort study in health care workers from a tertiary care hospital.
    Arankalle V; Kulkarni-Munje A; Kulkarni R; Palkar S; Patil R; Oswal J; Lalwani S; Mishra AC
    Front Immunol; 2022; 13():928501. PubMed ID: 36211366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estimation of SARS-CoV-2 IgG Antibodies in Healthcare Worker-Administered Covishield and Covaxin Vaccines at a Tertiary Care Hospital in Jharkhand, India.
    Singh B; Seema K; Mahuli AV; Kumar A; Boipai M; Sharma AK; Kumar M; Kumar S; Chandra S; Shahi AK
    Cureus; 2023 Oct; 15(10):e47566. PubMed ID: 38021860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adverse drug reaction profile of oseltamivir in Indian population: A prospective observational study.
    Anovadiya AP; Barvaliya MJ; Shah RA; Ghori VM; Sanmukhani JJ; Patel TK; Tripathi CB
    Indian J Pharmacol; 2011 May; 43(3):258-61. PubMed ID: 21713087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Adverse Reactions of Pfizer BioNTech COVID-19 Vaccine Booster Dose are Mild and Similar to the Second Dose Responses: A Retrospective Cross-Sectional Study.
    El-Shitany NA; Bagher AM; Binmahfouz LS; Eid BG; Almukadi H; Badr-Eldin SM; El-Hamamsy M; Mohammedsaleh ZM; Saleh FM; Almuhayawi MS; Alghamdi SA; Arab RA; Ali SS; Harakeh S; Alghamdi BS
    Int J Gen Med; 2022; 15():6821-6836. PubMed ID: 36051568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adverse events following COVID-19 vaccination among pregnant women attending primary health centers: An active-surveillance study.
    Goruntla N; Karisetty B; Nandini N; Bhupasamudram B; Gangireddy HR; Veerabhadrappa KV; Ezeonwumelu JOC; Bandaru V
    Vacunas; 2023 May; ():. PubMed ID: 37362835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of COVID-19 vaccines (Sputnik V, AZD-1222, and Covaxin) side effects among healthcare workers in Birjand city, Iran.
    Zare H; Rezapour H; Mahmoodzadeh S; Fereidouni M
    Int Immunopharmacol; 2021 Dec; 101(Pt B):108351. PubMed ID: 34801416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spontaneous reporting of adverse reactions associated with the COVID-19 vaccine in health care professionals: A descriptive observational study conducted in a Portuguese hospital.
    Teófilo VSG; Pinho PRA; Cordeiro GJ; Saldanha NAF; Matos PMM; Ribeiro RAM; Moreira SM; Miller MSF; Dias ARM; Couto MFR; Norton PMPNS
    Porto Biomed J; 2023; 8(3):e219. PubMed ID: 37383526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How safe is COVID-19 vaccination among pregnant women and its outcome - A hospital-based retrospective study in Indian population.
    Pandit NB; Fulmali PR; Chandrayan P; Chauhan K; Bhil DL; Rasania MN
    J Family Med Prim Care; 2023 Sep; 12(9):2140-2145. PubMed ID: 38024942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perception, acceptance, and adverse effects of COVID-19 vaccines: Insights from Indian population.
    Kumawat R; Nimesh A; Jalandra R; Agrawal S; Srinivas H; Ahirwar AK
    J Family Med Prim Care; 2024 Mar; 13(3):1062-1067. PubMed ID: 38736779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of Covid-19 vaccines (CovishieldTM and Covaxin ®) in healthcare workers in Mumbai, India: A retrospective cohort analysis.
    Contractor A; Shivaprakash S; Tiwari A; Setia MS; Gianchandani T
    PLoS One; 2022; 17(10):e0276759. PubMed ID: 36301977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.